Roche
Also, Japan has approved iRhythm's AI-based continuous ECG monitoring system.
Also, a startup in India has received seed funding to expand further its VR-based mental health DTx.
The pharma giant will integrate more than 20 AI algorithms from eight collaborators into its navify Digital Pathology enterprise software to help improve pathology workflows.
The partnership aims to raise patient safety, boost cost-effectiveness and improve care by combining Glytec's software with Roche's system.
The pharma giant will also pay $55 million to fund the point-of-care diagnostics platform until the acquisition closes, which is expected to occur by mid-2024.
Roche will leverage PicnicHealth's real-world datasets for Alzheimer’s Disease, Alzheimer’s Disease-related dementia and myasthenia gravis.
Also, Roche and Astellas have combined their diabetes management solutions.
It simplifies access to Roche India's cancer support programme.
Dr. Oliver Bleck, area head of Europe South at Roche, describes the pharma giant's work in personalized medicine.
The companies said their long-term goal is to develop and offer more digital health tools "through a multi-partner ecosystem" as well as advocate for reimbursement options.